Acro Biomedical Co (Acro Biomedical Co) EBIT per Share : $-0.25 (TTM As of Jun. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Acro Biomedical Co EBIT per Share?

Acro Biomedical Co's EBIT per Share for the three months ended in Jun. 2023 was $-0.05. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.25.

During the past 3 years, the average EBIT per Share Growth Rate was -208.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Acro Biomedical Co's EBIT per Share or its related term are showing as below:

ACBM' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -208.4 Med: -158.2 Max: -108
Current: -208.4

During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Acro Biomedical Co was -108.00% per year. The lowest was -208.40% per year. And the median was -158.20% per year.

ACBM's 3-Year EBIT Growth Rate is not ranked
in the Medical Distribution industry.
Industry Median: 9.1 vs ACBM: -208.40

Acro Biomedical Co's EBIT for the three months ended in Jun. 2023 was $-3.20 Mil.

Acro Biomedical Co EBIT per Share Historical Data

The historical data trend for Acro Biomedical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acro Biomedical Co EBIT per Share Chart

Acro Biomedical Co Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Dec20

Dec21

Dec22

EBIT per Share

Get a 7-Day Free Trial

0.01

-0.01

-0.14

-0.26

Acro Biomedical Co Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
EBIT per Share	Get a 7-Day Free Trial															-0.07	-0.07	-0.07	-0.07	-0.05

Acro Biomedical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Acro Biomedical Co's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-15.87	/	60.042
=	-0.26

Acro Biomedical Co's EBIT per Share for the quarter that ended in Jun. 2023 is calculated as

	EBIT per Share		(Q: Jun. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.195	/	60.042
=	-0.05

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.25

Acro Biomedical Co (OTCPK:ACBM) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Acro Biomedical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Acro Biomedical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Acro Biomedical Co (Acro Biomedical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Acro Biomedical Co Ltd (OTCPK:ACBM) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038

Website

http://www.acrobiomedical.com

Acro Biomedical Co Ltd develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder.

Executives

Pao-chi Chu

director, 10 percent owner, officer: CEO

2F, NO. 356 SEC 1. DUNHUA S. RD., DA'AN DISTRICT, TAIPEI CITY F5 106

Acro Biomedical Co (Acro Biomedical Co) Headlines

No Headlines